In this episode of IDEA Collider, we are joined by Alex Telford, a biotech founder, writer, and thinker based in the San Francisco Bay Area. As the co-founder of Convoke Bio, Alex discusses his journey from studying biochemistry at UCL to founding a company that develops software tools for streamlining biopharmaceutical workflows.

The conversation dives into the impact of AI and language models on the biotech industry, addressing inefficiencies in drug development, and exploring the potential of synthetic biology and personalized medicine. The discussion also touches on the future of drug discovery, China's role in biotech, and the challenges of understanding neuroscience and consciousness. Don't miss this insightful discussion on the future of biopharma innovation!

00:00 Welcome to Idea Collider

00:04 Introducing Alex Telford

01:59 Alex's Journey from UCL to Convoke Bio

05:29 The Mission and Work of Convoke Bio

07:57 Challenges in Pharma Decision Making

14:05 The Role of AI in Pharma

18:26 Knowledge Management and AI

27:58 Staying Updated in the Fast-Moving AI Field

30:25 AI's Impact on Industry Economics

31:38 AI in Clinical Trials and Drug Development

35:56 China's Role in Drug Discovery

39:24 Neuroscience and AI: Blurring the Lines

46:05 Future Predictions in Pharma

51:20 Addressing Cognitive Bias in Pharma

53:13 Concluding Thoughts and Future Directions

Keep up with Alex Telford;

LinkedIn: https://www.linkedin.com/in/alexander-telford/

Website: atelfo.github.io

X: https://twitter.com/atelfo

Substack: atelfo.substack.com

Follow Mike Rea On;

Website: https://www.ideapharma.com/

X: https://x.com/ideapharma

LinkedIn: https://www.linkedin.com/in/bigidea/

Listen to more fantastic podcast episodes: https://podcast.ideapharma.com/